Plenful, a platform specializing in workflow automation to streamline pharmacy and healthcare operations, has announced $9 million in funding, spearheaded by Bessemer Venture Partners. The…
View More Plenful Introduces AI-Driven Workflow Automation to Healthcare and Pharmacy Operations
Evozyne has successfully concluded an $81 million Series B investment round aimed at advancing the biotech company’s generative AI-powered drug discovery platform and product development.…
View More Evozyne Secures $81 Million Funding Round to Propel Generative AI for Therapeutic Discovery and Drug Development
Merck, a global leader in science and technology, has unveiled two strategic collaborations focused on leveraging the capabilities of artificial intelligence (AI) for drug discovery.…
View More Merck Announces Strategic Collaborations with BenevolentAI and Exscientia to Drive AI-Powered Drug Discovery
Persist AI, a trailblazer in AI-driven drug formulation, has successfully concluded an oversubscribed $4M financing round post their YCombinator program completion, the prestigious San Francisco-based…
View More Persist AI Raises $4M in Seed Financing
Technology analyst firm Transforma Insights’ report ‘Artificial Intelligence Market Forecast Report 2020-2030’ details the results of its forecast of the Artificial Intelligence market. Key findings…
View More Transforma Insights: AI will grow ten-fold over next decade
Synthetica Bio, a fledgling enterprise operating within the biopharmaceutical realm, has made its much-anticipated debut, bolstered by substantial venture funding from prominent investors. Spearheaded by…
View More Synthetica Bio Commences Operations with Substantial Venture Funding to Create Tailor-Made Generative AI Platform for Biopharma